Page 4 - Piramal Enterprises

Oaktree Capital, Piramal Enterprises, Adani revise offers for bankrupt DHFL

Offer includes deferred payment, cash with HFC

Three directors quit Piramal Entreprises board to aid succession planning

Keki Dadiseth, Dr. R.A. Mashelkar and Prof. Goverdhan Mehta, independent directors on the board of Piramal Enterprises have resigned, the company informed BSE

Piramal Enterprises appoints two independent directors to its board

Piramal Enterprises said it has appointed Snapdeal CEO Kunal Bahl and Economic Law Practice Managing Partner Suhail Nathani as independent directors to its board.

Piramal Pharma readies war chest for potential acquisition targets

A decade after Piramal sold its domestic formulations business to Abbott Laboratories for $3.72 billion, the group is now looking at re-entering the space in India

LIC Housing invests in SPR City, Piramal Enterprises exits from project

The company's Director Chetan Bohra said that the capital raised would be utilised for advacing the construction and ensuring the completion of the residential project within this financial year

CCI gives approval to Carlyle Group's 20% buy in Piramal Pharma

Piramal Enterprises, in a regulatory filing, in June had said Carlyle Group Inc would buy 20 per cent stake in Piramal Pharma for around $490 million (over Rs 3,700 crore).

Stock calls by Nilesh Jain of Anand Rathi: Buy Glenmark Pharma, Tata Elxsi

Glenmark's stock has reclaimed its short term 21-DMA

Piramal Enterprises Q1 profit up 11% at Rs 496 cr; revenue at Rs 2,937 cr

Consolidated revenue from operations stood at Rs 2,937.34 crore during the quarter under review as against Rs 3,186.82 crore in the same period a year ago

India Inc's deal activity at a 6-year low amid Covid-19 pandemic

Last year, India Inc sealed deals worth $88.88 billion in the January-July period, but this year the total transactions are $56.73 billion, fueled mainly by RIL-Jio deals

Piramal seeks investors, hedge funds to raise capital for unfinished houses

India's real estate market is grappling with a lingering lockdown that's slowed construction and sharply crimped new sales in an already struggling market.

Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn

Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd

Top stock picks by CapitalVia Global Research: Buy RIL, Piramal Enterprises

The level of 9,200 might act as a base for Nifty's weekly expiry

Nifty's major support at 9,000 for weekly expiry: Gaurav Garg of CapitalVia

Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

Piramal Enterprises tumbles 10% after posting net loss of Rs 1,703 cr in Q4

The company made provisions in the financial services business to the tune of Rs 2,963 crore in Q4FY20, up more than 200 per cent

KKR likely to pick 20% stake in Piramal Enterprises for Rs 3,500 crore

Talks are still in advanced stage with KKR, say bankers

Piramal, Tata Motors, Coastal Gujarat to issue NCDs to raise Rs 5,700 crore

Piramal Enterprises's (PEL's) Rs 3,000 crore fundraising is through debentures.

Nifty needs to hold 9,000 for further up move: Gaurav Garg of CapitalVia

Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

Piramal Enterprises surges over 7.5% in early trade, retreats later

The deal, once completed, may value the Piramal Group's overall pharma business at $2.5 billion, the report added.

Piramal Enterprises Q3 pre-tax profit up 6.6% to Rs 954 cr

Net profit after tax up 20% to Rs 724 cr, revenues rise 9% to Rs 3,806 cr, Gross NPAs up by 1.8%

Piramal Enterprises' Rs 3,600-crore rights issue fully subscribed

Based on preliminary information, the total applications from ASBA and non-ASBA have exceeded the issue amount to eligible equity shareholders, and therefore, oversubscribed, the firm said